Necrotizing enterocolitis is one disease with many origins and potential means of prevention

Pathophysiology

Volumn 21, Issue 1, 2014, Pages 13-19

  Gordon, Phillip V ^a,b   Swanson, Jonathan R ^c  

^a Pediatrix Obstetrix Center for Research and Education   (United States)

^b Sacred Heart Children's Hospital   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Necrotizing enterocolitis; Preterm infant; Prevention; Quality improvement

Indexed keywords

ARTICLE; BREAST FEEDING; CLINICAL EFFECTIVENESS; HEALTH CARE QUALITY; HUMAN; INNATE IMMUNITY; LYMPHOCYTOSIS; MEDICAL HISTORY; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 84896078626     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2013.11.015     Document Type: Article

References (61)

1. Rabl R. Necrotizing enterocolitis in premature infants. Beitr. Pathol. Anat. 1957, 117:266-282.
2. Eroess A., Loerinczi K., Nemeth N. Enterocolitis necroticans in newborn infants. Kinderarztl. Prax. 1959, 27:403-406.
3. Berdon W.E., Grossman H., Baker D.H., Mizrahi A., Barlow O., Blanc W.A. Necrotizing enterocolitis in the premature infant. Radiology 1964, 83:879-887.
4. Mizrahi A., Barlow O., Berdon W., Blanc W.A., Silverman W.A. Necrotizing enterocolitis in the premature infant. J. Pediatr. 1965, 66:697-705.
5. Bell M.J., Ternberg J.L., Feigin R.D., Keating J.P., Marshall R., Barton L., Brotherton T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann. Surg. 1978, 187:1-7.
6. Kliegman R.M., Fanaroff A.A. Neonatal necrotizing enterocolitis in the absence of pneumatosis intestinalis. Am. J. Dis. Child. 1982, 136:618-620.
7. Kliegman R.M., Fanaroff A.A. Neonatal necrotizing enterocolitis: a nine-year experience. Am. J. Dis. Child. 1981, 135:603-607.
8. Grosfeld J.L., Cheu H., Schlatter M., West K.W., Rescorla F.J. Changing trends in necrotizing enterocolitis. Experience with 302 cases in two decades. Ann. Surg. 1991, 214:300-306.
9. Holman R.C., Stoll B.J., Clarke M.J., Glass R.I. The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am. J. Public Health 1997, 87:2026-2031.
10. Luig M., Lui K., NSW & ACT NICUS Group Epidemiology of necrotizing enterocolitis - Part I: changing regional trends in extremely preterm infants over 14 years. J. Paediatr. Child Health 2005, 41:169-173.
11. Battaglia J.D. Neonatal surgery: changing patterns 1972-1980. J. Pediatr. Surg. 1982, 17:666-669.
12. Kliegman R.M., Hack M., Jones P., Fanaroff A.A. Epidemiologic study of necrotizing enterocolitis among low-birth-weight infants. Absence of identifiable risk factors. J. Pediatr. 1982, 100:440-444.
13. Walsh M.C., Kliegman R.M. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr. Clin. North Am. 1986, 33:179-201.
14. Porter A. Spontaneous pneumoperitoneum in the newborn: report of a case. N. Engl. J. Med. 1956, 254:694-696.
15. Aschner J.L., Deluga K.S., Metlay L.A., Emmens R.W., Hendricks-Munoz K.D. Spontaneous focal gastrointestinal perforation in very low birth weight infants. J. Pediatr. 1988, 113:364-367.
16. Gordon P., Rutledge J., Sawin R., Thomas S., Woodrum D. Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants. J. Perinatol. 1999, 19:573-577.
17. Gordon P.V., Young M.L., Marshall D.D. Focal small bowel perforation: an adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants. J. Perinatol. 2001, 21:156-160.
18. Garland J., Colleen A., Thomas P., Whitehead V., Brand J., Winston J., et al. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics 1999, 104:91-99.
19. Stark A.R., Carlo W.A., Tyson J.E., Papile L.-A., Wright L.L., Shankaran S., et al. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. N. Engl. J. Med. 2001, 344:95-101.
20. Vermont Oxford Network Steroid Study Group Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatrics 2001, 108:741-748.
21. Sinkin R., Harry D., Horgan M., Gallaher K., Cox C., Maniscalco W., et al. Early dexamethasone - attempting to prevent chronic lung disease. Pediatrics 2000, 105:542-548.
22. Gordon P.V. Understanding intestinal vulnerability to perforation in the extremely low birth weight infant. Pediatr. Res. 2009, 65:138-144.
23. Yee W.H., Soraisham A.S., Shah V.S., Aziz K., Yoon W., Lee S.K., the Canadian Neonatal Network Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics 2012, 129:e298-e304.
24. Jilling T., Simon D., Lu J., Meng F.J., Li D., Schy R., et al. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J. Immunol. 2006, 177:3273-3282.
25. Sodhi C.P., Neal M.D., Siggers R., Sho S., Ma C., Branca M.F., et al. Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology 2012, 143:708-718. 10.1053/j.gastro.2012.05.053.
26. Soliman A., Mechelsen K.S., Karahashi H., Lu J., Meng F.J., Qu X., et al. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. PLoS One 2010, 5:e15044.
27. Gribar S.C., Sodhi C.P., Richardson W.M., Anand R.J., Gittes G.K., Branca M.F., et al. Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J. Immunol. 2009, 182:636-646.
28. Good M., Sodhi C., Siggers R., Prindle T., Branca M., Russo A., et al. Epithelial Growth Factor Attenuates the Severity of Experimental Necrotizing Enterocolitis and Inhibits Toll-Like Receptor 4 Signaling in Enterocytes. E-PAS2011 2011, 2720.3.
29. Gordon P., Christensen R., Weitkamp J.H., Maheshwari A. Mapping the new world of necrotizing enterocolitis (NEC): review and opinion. e-J. Neonatol. Res. 2012, 2:145-172.
30. Gordon P.V., Swanson J.R., Attridge J.T., Clark R. Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria?. J. Perinatol. 2007, 27:661-671.
31. Gordon P.V. What progress looks like in NEC research. J. Perinatol. 2011, 31:149.
32. Clark R.H., Gordon P., Walker W.M., Laughon M., Smith P.B., Spitzer A.R. Characteristics of patients who die of necrotizing enterocolitis. J. Perinatol. 2012, 32:199-204.
33. Guthrie S.O., Gordon P.V., Thomas V., Thorp J.A., Peabody J., Clark R.H. Necrotizing enterocolitis among neonates in the United States. J. Perinatol. 2003, 23:278-285.
34. González-Rivera R., Culverhouse R.C., Hamvas A., Tarr P.I., Warner B.B. The age of necrotizing enterocolitis onset: an application of Sartwell's incubation period model. J. Perinatol. 2011, 31:519-523.
35. Bhandari V., Bizzarro M.J., Shetty A., Zhong X., Page G.P., Zhang H., et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006, 117:1901-1906.
36. Young C., Sharma R., Handfield M., Mai V., Neu J. Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention?. Pediatr. Res. 2009, 65:91R-97R.
37. Sampath V., Le M., Lane L., Patel A.L., Cohen J.D., Simpson P.M., et al. The NFKB1 (g.-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. J. Surg. Res. 2011, 169:e51-e57.
38. Prencipe G., Azzari C., Moriondo M., Devito R., Pezzullo M., et al. Association between mannose-binding lectin gene polymorphisms and necrotizing enterocolitis in preterm infants. J. Pediatr. Gastroenterol. Nutr. 2012, 55:160-165.
39. Carlisle E.M., Morowitz M.J. The intestinal microbiome and necrotizing enterocolitis. Curr. Opin. Pediatr. 2013, 25:382-387.
40. Indrio F., Neu J. The intestinal microbiome of infants and the use of probiotics. Curr. Opin. Pediatr. 2011, 23:145-150.
41. Alfaleh K., Anabrees J., Bassler D., Al-Kharfi T. Probiotics for the prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 2011, 3:CD005496.
42. Martin C.R. Probiotics for the prevention of necrotizing enterocolitis: not just which ones but also why?. J. Pediatr. Gastroenterol. Nutr. 2013, 57:3.
43. Patel R.M., Denning P.W. Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence. Clin. Pernatol. 2013, 40:11-25.
44. Swanson J.R. Necrotizing enterocolitis: is it time for zero tolerance?. J. Perinatol. 2013, 33:1-2.
45. Gephart S.M., McGrath J.M., Effken J.A., Halpern M.D. Necrotizing enterocolitis risk: state of the science. Adv. Neonatal Care 2012, 12:77-87.
46. Torrazza R.M., Neu J. The altered gut microbiome and necrotizing enterocolitis. Clin. Perinatol. 2013, 40:93-108.
47. Neu J., Walker W.A. Necrotizing enterocolitis. N. Engl. J. Med. 2011, 364:255-264.
48. Singh R., Visintainer P.F., Frantz I.D., Shah B.L., Meyer K.M., Favila S.A., et al. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. J. Perinatol. 2011, 31:176-182.
49. Christensen R.D., Lambert D.K., Henry E., Wiedmeier S.E., Snow G.L., Baer V.L., et al. Is 'transfusion-associated necrotizing enterocolitis' an authentic pathogenic entity?. Transfusion (Paris) 2010, 50:1106-1112.
50. Christensen R.D. Associations between "early" red blood cell transfusion and severe intraventricular hemorrhage, and between "late" red blood cell transfusion and necrotizing enterocolitis. Semin. Perinatol. 2012, 36:283-289.
51. La Gamma E.F., Blau J. Transfusion-related acute gut injury: feeding, flora, flow, and barrier defense. Semin. Perinatol. 2012, 36:294-305.
52. Amin S.C., Remon J.L., Subbarao G.C., Maheshwari A. Association between red cell transfusions and necrotizing enterocolitis. J. Matern. Fetal Neonatal Med. 2012, 25:85-89.
53. Hair A.B., Swanson J.R., Attridge J.T. Lymphocytosis at necrotizing enterocolitis presentation is associated with higher mortality, increased feeding volumes and more formula exposure in an 11 year, single center retrospective study. e-J. Neonatal Res. 2011, 2:37-43.
54. Gordon P.V., Thibeau S., Pennier C., Ginsberg H., Lunyong V., Cortez M., et al. Is lymphocytosis an adjunct predictor of NEC mortality in low gestation infants?. e-J. Neonatal Res. 2012, 2:29-36.
55. Meinzen-Derr J., Morrow A.L., Hornung R.W., Donovan E.F., Dietrich K.N., Succop P.A. Epidemiology of necrotizing enterocolitis temporal clustering in two neonatology practices. J. Pediatr. 2009, 154:656-661.
56. Christensen R.D., Lambert D.K., Gordon P.V., Baer V.L., Gerday E., Henry E. Neonates presenting with bloody stools and eosinophilia can progress to two different types of necrotizing enterocolitis. J. Perinatol. 2012, 32:874-879.
57. Srinivasan P., Brandler M., D'Souza A., Millman P., Moreau H. Allergic enterocolitis presenting as recurrent necrotizing enterocolitis in preterm neonates. J. Perinatol. 2010, 30:431-433.
58. Benjamin J., Chong E., Reynolds J., Gordon P.V. Detailed analysis of NEC risks across a decade in a low incidence NICU: can we drive the incidence of NEC toward zero?. e-J. Neonatol. Res. 2012, 2:181-189.
59. Sharma R., Garrison R.D., Tepas D., Mollitt D.L., Pieper P., Hudak M.L., et al. Rotavirus-associated necrotizing enterocolitis: an insight into a potentially preventable disease?. J. Pediatr. Surg. 2004, 39:453-457.
60. Stritzke A.I., Smyth J., Synnes A., Lee S.K., Shah P.S. Transfusion-associated necrotizing enterocolitis in neonates. Arch. Dis. Child. Fetal Neonatal Ed. 2013, 98:F10-F14.
61. Lorch S.A., Maheshwari P., Even-Shoshan O. The impact of certificate of need programs on neonatal intensive care units. J. Perinatol. 2012, 32:39-44.